Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 13/20 | 0.81 |
| ▸ | CCR3 | P51677 | 1/20 | 0.69 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.67 |
| ▸ | ATM | Q13315 | 1/20 | 0.66 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.66 |
| ▸ | DRD4 | P21917 | 3/20 | 0.64 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.64 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Panuramine SCHEMBL2037759 | 0.90 | MCHR1 (0.83) | MCHR1CCR3SIGMAR1DRD4SLC6A12 | |
| Panuramine SCHEMBL9749426 | 0.89 | MCHR1 (0.81) | MCHR1CCR3SIGMAR1DRD4SLC6A12 | |
| SCHEMBL9601120 | 0.88 | MCHR1 (0.80) | MCHR1CCR3SIGMAR1DRD4SLC6A12 | |
| SCHEMBL4762592 | 0.84 | MCHR1 (0.80) | MCHR1CCR3SIGMAR1DRD4SLC6A12 | |
| SCHEMBL2564778 | 0.83 | MCHR1 (0.87) | MCHR1CCR3SIGMAR1DRD4SLC6A12 | |
| SCHEMBL9592451 | 0.82 | DRD4 (0.71) | MCHR1CCR3SIGMAR1DRD4SLC6A12 | |
| SCHEMBL11057431 | 0.82 | CCR3 (0.84) | MCHR1CCR3DRD4 | |
| SCHEMBL9592427 | 0.82 | MCHR1 (0.70) | MCHR1CCR3SIGMAR1DRD4SLC6A12 | |
| SCHEMBL9792346 | 0.82 | MCHR1 (0.84) | MCHR1CCR3SIGMAR1ATMGPR55 | |
| SCHEMBL9594285 | 0.81 | DRD4 (0.75) | MCHR1CCR3DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5212179-A | Antidepressants | JOHN WYETH AND BROTHER LIMITED (GB) | 1993-05-18 | — | — | US | disclosed |
| US-4985438-A | PSYCHOTROPIC ACTIVITY, ANTIDEPRESSANTS | JOHN WYETH & BROTHER, LIMITED (GB) | 1991-01-15 | — | — | US | disclosed |
| US-4806552-A | ANTIDEPRESSANTS | JOHN WYETH & BROTHER, LIMITED (GB) | 1989-02-21 | — | — | US | disclosed |
| US-4722930-A | ANTIDEPRESSANTS | JOHN WYETH AND BROTHER LIMITED (GB) | 1988-02-02 | — | — | US | disclosed |
| US-4563466-A | ANTISEROTONINE | JOHN WYETH & BROTHER LIMITED (GB) | 1986-01-07 | — | — | US | disclosed |
| EP-0035374-B1 | PIPERIDYL - UREA, - THIOUREA AND - GUANIDINE DERIVATIVES, AND INTERMEDIATES THEREFOR, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES | JOHN WYETH & BROTHER LIMITED (GB) | 1985-01-30 | — | — | EP | disclosed |
| US-4426387-A | Piperid-4-yl ureas and thio ureas used as anti-depressant agents | JOHN WYETH & BROTHER LTD. (GB) | 1984-01-17 | — | — | US | disclosed |
| EP-0035374-A2 | Piperidyl - urea, - thiourea and - guanidine derivatives, and intermediates therefor, processes for preparing them and pharmaceutical compositions containing the derivatives | JOHN WYETH & BROTHER LIMITED (GB) | 1981-09-09 | — | — | EP | disclosed |